New Home Treatment for Jaundice in Newborns Introduced in Scotland
Scotland’s largest health board has launched an innovative service allowing newborns diagnosed with jaundice to receive essential therapy in the comfort of their homes. Utilising a specialised sleeping bag-like device, this service aims to enhance the treatment experience for families with infants affected by this common condition.
Advancements in Jaundice Treatment
The newly established Hospital at Home programme permits eligible infants to undergo phototherapy, which employs therapeutic light for treatment. Neonatal jaundice, which affects approximately 60% of newborns, results in noticeable yellowing of the skin and eyes due to elevated bilirubin levels. While the condition typically self-resolves as a baby’s liver develops, intervention is necessary if bilirubin concentrations become excessive.
The Benefits of Home-Based Care
Previously, families were required to return to the hospital for treatment, often disrupting the early days of bonding at home. The new approach from NHS Greater Glasgow and Clyde, facilitated by the neonatal unit at the Royal Hospital for Children in Glasgow, enables infants to be treated safely in their own environment.
Kayleigh Cunningham, a senior nurse within the programme, noted that symptom onset generally occurs around the 72-hour mark after birth. She emphasised the emotional toll on families when they are forced to leave their homes shortly after welcoming a new baby.
Real-Life Impact: A Family’s Experience
Alicia Hardie and her partner, Mark Donohue, expressed their appreciation for the new service after their daughter, Cora, was born prematurely. Initially unaware of the home treatment option, they remained hospitalized longer than anticipated due to Cora’s high bilirubin levels.
“After an early birth and the back and forth for blood tests, the service was exactly what we needed. We could finally relax at home and start our new life together,” said Miss Hardie.
She added that the equipment proved to be user-friendly, and after just two days of therapy at home, Cora passed her subsequent blood test and is now thriving.
Background
Jaundice is a prevalent concern among newborns, and treatment usually requires phototherapy over several days in clinical settings. The introduction of options that allow at-home care represents a significant improvement in neonatal healthcare, reducing the stress on families and enhancing the recovery environment for infants.
This development underscores a shift in healthcare practices, prioritising patient comfort and familial cohesion during a critical period of adjustment for new parents.
Source: Original Article
